scholarly journals Analysis of Consumer Exposure Cases for Alcohol-Based Disinfectant and Hand Sanitizer Use against Coronavirus Disease 2019 (COVID-19)

Author(s):  
Hyukmin Kweon ◽  
Jae-Won Choi ◽  
Seong-Yong Yoon

The development and distribution of vaccines and treatments as well as the use of disinfectants and hand sanitizers to cope with coronavirus disease 2019 (COVID-19) infection has increased rapidly. As the use of disinfectants and hand sanitizers increased, the number of unintended exposures to these substances also increased. A total of 8016 cases of toxic exposure to disinfectants and hand sanitizers were reported to the American Association of Poison Control Centers (AAPCC) from 1 January 2017 to 30 May 2021. The cases have been characterized by substance, sex, patient age, exposure reason and site, treatments received, and outcomes. The number of exposures correlates closely to the rise of COVID-19 cases, rising significantly in March 2020. About half of the total cases involved children less than 10 years old and 97% of those exposures per year were unintentional. In addition, the most common exposure site was the patient’s own residence. Over-exposure to disinfectants and hand sanitizers can cause symptoms such as burning and irritation of the eyes, nose, and throat, coughing, chest tightness, headache, choking, and, in severe cases, death.

2001 ◽  
Vol 19 (5) ◽  
pp. 337-395 ◽  
Author(s):  
Toby L. Litovitz ◽  
Wendy Klein-Schwartz ◽  
Suzanne White ◽  
Daniel J. Cobaugh ◽  
Jessica Youniss ◽  
...  

2005 ◽  
Vol 23 (5) ◽  
pp. 589-666 ◽  
Author(s):  
William A. Watson ◽  
Toby L. Litovitz ◽  
George C. Rodgers ◽  
Wendy Klein-Schwartz ◽  
Nicole Reid ◽  
...  

2002 ◽  
Vol 36 (11) ◽  
pp. 1698-1703 ◽  
Author(s):  
Jean C McGrath ◽  
Wendy Klein-Schwartz

OBJECTIVE: To examine the epidemiology and toxicity of guanfacine exposures in children and adolescents reported to poison control centers. METHODS: Guanfacine exposures reported to the American Association of Poison Control Centers Toxic Exposure Surveillance System from 1993 to 1999 in children and adolescents <19 years of age were analyzed. RESULTS: There were 870 cases that met the inclusion criteria: 478 (54.9%) were children <6 years old, 304 (34.9%) were 6–12 years old, and 88 (10.1%) were adolescents 13–18 years old. The number of cases increased eight-fold over the 7-year period, with the largest increase in children <13 years of age. Analysis showed 29.7% of exposures were managed on site (non-healthcare facility) and 68.3% were managed in a healthcare facility. There were no symptoms in 546 (62.8%) children. In 324 symptomatic children, the most common symptoms were drowsiness/lethargy (76.8%), bradycardia (30.0%), and hypotension (25.8%). The majority of cases were acute (77.5%), 182 (20.9%) were acute-on-chronic, and 14 (1.6%) were chronic. Children aged 6–12 years represented the majority of the acute-on-chronic and chronic exposures with (n = 118). Overall, there were 195 (22.4%) exposures coded as minor, 121 (13.9%) as moderate, and 8 (0.9%) as major effects. CONCLUSIONS: These data demonstrated a trend of increasing numbers of guanfacine exposures annually. Although the majority of children experienced minimal or no toxicity, serious toxicity can occur.


1997 ◽  
Vol 15 (5) ◽  
pp. 447-500 ◽  
Author(s):  
Toby L Litovitz ◽  
Martin Smilkstein ◽  
Linda Felberg ◽  
Wendy Klein-Schwartz ◽  
Randall Berlin ◽  
...  

2002 ◽  
Vol 20 (5) ◽  
pp. 391-452 ◽  
Author(s):  
Toby L. Litovitz ◽  
Wendy Klein-Schwartz ◽  
George C. Rodgers ◽  
Daniel J. Cobaugh ◽  
Jessica Youniss ◽  
...  

2003 ◽  
Vol 21 (5) ◽  
pp. 353-421 ◽  
Author(s):  
William A Watson ◽  
Toby L Litovitz ◽  
George C Rodgers ◽  
Wendy Klein-schwartz ◽  
Jessica Youniss ◽  
...  

1998 ◽  
Vol 16 (5) ◽  
pp. 443-497 ◽  
Author(s):  
Toby L Litovitz ◽  
Wendy Klein-Schwartz ◽  
K.Sophia Dyer ◽  
Michael Shannon ◽  
Shannon Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document